79.23
Precedente Chiudi:
$84.13
Aprire:
$84.5
Volume 24 ore:
9.62M
Relative Volume:
0.97
Capitalizzazione di mercato:
$13.36B
Reddito:
$803.32M
Utile/perdita netta:
$-709.10M
Rapporto P/E:
-10.16
EPS:
-7.8003
Flusso di cassa netto:
$-212.68M
1 W Prestazione:
-8.35%
1M Prestazione:
-1.60%
6M Prestazione:
+34.29%
1 anno Prestazione:
+54.69%
Tempus Ai Inc Stock (TEM) Company Profile
Nome
Tempus Ai Inc
Settore
Industria
Telefono
800-976-5448
Indirizzo
600 WEST CHICAGO AVENUE, CHICAGO
Confronta TEM con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
TEM
Tempus Ai Inc
|
79.23 | 14.62B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
VEEV
Veeva Systems Inc
|
277.94 | 45.70B | 2.97B | 809.93M | 1.33B | 4.87 |
![]()
DOCS
Doximity Inc
|
74.27 | 13.84B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
94.26 | 8.09B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
37.04 | 6.58B | 906.14M | -52.62M | 89.62M | -0.3621 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-09-02 | Iniziato | H.C. Wainwright | Buy |
2025-04-21 | Iniziato | BTIG Research | Buy |
2025-02-25 | Downgrade | JP Morgan | Overweight → Neutral |
2025-02-12 | Downgrade | William Blair | Outperform → Mkt Perform |
2025-02-05 | Ripresa | TD Cowen | Buy |
2024-12-13 | Iniziato | Wolfe Research | Outperform |
2024-12-09 | Iniziato | Guggenheim | Buy |
2024-11-11 | Downgrade | Stifel | Buy → Hold |
2024-10-02 | Downgrade | BofA Securities | Buy → Neutral |
2024-08-12 | Iniziato | Piper Sandler | Neutral |
2024-07-09 | Iniziato | BofA Securities | Buy |
2024-07-09 | Iniziato | JP Morgan | Overweight |
2024-07-09 | Iniziato | Longbow | Buy |
2024-07-09 | Iniziato | Loop Capital | Buy |
2024-07-09 | Iniziato | Morgan Stanley | Overweight |
2024-07-09 | Iniziato | Needham | Buy |
2024-07-09 | Iniziato | Stifel | Buy |
2024-07-09 | Iniziato | TD Cowen | Buy |
2024-07-09 | Iniziato | William Blair | Outperform |
Mostra tutto
Tempus Ai Inc Borsa (TEM) Ultime notizie
Cathie Wood Dumps $5.2 Million Worth of This AI Stock, Here's What Ark Bought Instead - Yahoo Finance
Renalytix Updates Revenue Guidance Amid New Tempus Collaboration - TipRanks
FDA Clears Tempus AI’s RNA-Based Analytical Tool - Medical Product Outsourcing
Cathie Wood Continues Selling Tempus AI and Roku Shares - MSN
39,934 Shares in Tempus AI, Inc. $TEM Purchased by Bouvel Investment Partners LLC - MarketBeat
Exchange Traded Concepts LLC Cuts Stock Position in Tempus AI, Inc. $TEM - MarketBeat
Renalytix shares slump as revenue guidance revised after Tempus deal - MarketScreener
Tempus AI Enhances Cancer Research Tools With FDA-Cleared xR IVD - sharewise.com
Surge in Tempus AI Stock: What’s Behind It? - StocksToTrade
Tempus AI (NASDAQ:TEM) Stock Price Up 1.3%Time to Buy? - MarketBeat
Why Is Tempus AI Stock (TEM) Rising in Premarket Trading Today? - TipRanks
Tempus AI (NASDAQ:TEM) Hits New 12-Month HighTime to Buy? - MarketBeat
Voya Investment Management LLC Purchases Shares of 35,585 Tempus AI, Inc. $TEM - MarketBeat
Renalytix Projects Revenue Growth with Tempus Collaboration - TipRanks
Cathie Wood Continues to Offload Roku and Tempus AI Stocks - TipRanks
3 Big Short Interest Names With Bullish Setups - MarketBeat
AI-Tied IBD 50 Stock Hits Record High, And Then Yo-Yoes - Investor's Business Daily
Tempus AI stock hits all-time high of 92.68 USD - Investing.com India
Tempus AI stock hits all-time high of 92.68 USD By Investing.com - Investing.com South Africa
Best Artificial Intelligence Stocks To Follow NowSeptember 22nd - MarketBeat
Hims & Hers Expands Care Ecosystem via Global and Digital Innovation - TradingView
Brera Holdings (NASDAQ: BREA) Jumps as ARK Invest Buys $49.7M Stake, Trims Roku and Tempus AI - The Globe and Mail
Tempus AI (TEM) Stock: FDA Clearance Drives Shares to All-Time High - parameter.io
Tempus AI Shares Up After FDA Clearance for In Vitro Diagnostic Device - 富途牛牛
Tempus AI’s Shares Skyrocket: Investment or Bubble? - StocksToTrade
Tempus AI jumps on FDA clearance of RNA-based testing tech - Sherwood News
Tempus receives FDA clearance for RNA-based diagnostic device - Investing.com
Tempus AI (TEM) Stock Is Rising Monday: What's Going On? - Benzinga
Tempus AI stock rises after FDA clearance for RNA sequencing device By Investing.com - Investing.com South Africa
Tempus AI stock rises after FDA clearance for RNA sequencing device - Investing.com
Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device - Business Wire
How Investors May Respond To Tempus AI (TEM) Gaining FDA Clearance for Enhanced Diagnostics and Expanding Partnerships - simplywall.st
Cathie Woods' Ark Invest weekly recap: lifts stake in Bullish and Brera, trims Roku and Tempus AI - MSN
Cathie Wood's Ark Invest weekly recap: lifts stake in Bullish and Brera, trims Roku and Tempus AI (ARKK:BATS) - Seeking Alpha
Tempus AI, Inc. $TEM Shares Sold by SeaCrest Wealth Management LLC - MarketBeat
Tempus Ai Inc Azioni (TEM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):